Trial Profile
Clinical Trials Insight: 700026915
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Sep 2007
Price :
$35
*
At a glance
- Drugs Vigabatrin (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- 13 Sep 2007 New trial record.